- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 215/40 - Nitrogen atoms attached in position 8
Patent holdings for IPC class C07D 215/40
Total number of patents in this class: 173
10-year publication summary
|
12
|
8
|
10
|
13
|
15
|
8
|
18
|
9
|
10
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| 60 Degrees Pharmaceuticals, LLC | 24 |
6 |
| The United States of America as represented by the Secretary of the Army | 1215 |
5 |
| Calgent Biotechnology Co., Ltd. | 10 |
5 |
| Centre National de La Recherche Scientifique | 10464 |
4 |
| Agios Pharmaceuticals, Inc | 216 |
4 |
| Guangdong University of Technology | 583 |
4 |
| Incyte Corporation | 1022 |
4 |
| The Research Foundation for The State University of New York | 1621 |
4 |
| The United States Government AS represented by The Department of Veterans Affairs | 1191 |
4 |
| Pharma Cinq, LLC | 57 |
4 |
| Glaxo Group Limited | 4063 |
3 |
| Syngenta Participations AG | 1904 |
3 |
| National Taiwan University | 1227 |
3 |
| Ontario Institute for Cancer Research (oicr) | 81 |
3 |
| Otago Innovation Limited | 59 |
3 |
| Southern Research Institute | 210 |
3 |
| X4 Pharmaceuticals, Inc. | 82 |
3 |
| ExxonMobil Chemical Patents Inc. | 3977 |
2 |
| The Regents of the University of Michigan | 4711 |
2 |
| Tsinghua University | 5940 |
2 |
| Other owners | 102 |